OakChart

Revvity Inc

RVTYHealthcare·Diagnostics & Research·USA·Large·NYSE·Nov 11 • 8:21 AM ET

160.00+0.90 (0.57%)
2026-11-11 14:22 CET
Market cap
17,753.33 USD m
Revenue, TTM
2,941.76 USD m
Net income, TTM
253.74 USD m
Free cash flow, TTM
588.31 USD m
EPS diluted, TTM
2.26
P/E
70.92
Compare

Price

RVTY against its 20, 50 and 200-day averages
2050200miss
100.00120.00140.00160.002.2M4.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26RVTYclose 160.0020-day 157.8850-day 149.43200-day 113.58160.00

6.8% under 171.74 on 3 Nov 2026. Last 15 sessions, 15.0% high to low

Profile

RVTY
52-week range, 87% of the way up
81.22171.74

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

IndexS&P 500, RUI
Employees11000
IPOJul 06, 1965
Beta1.08
ATR, 14d7.43
Rel volume0.05
Short float5.88%
Insider own0.47%
Inst own105.06%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap17.85B
Enterprise Value20.03B
Income253.42M
Sales2.94B
Book/sh65.14
Cash/sh5.32
Dividend Est.0.28 (0.17%)
Dividend TTM0.28 (0.18%)
Dividend Ex-DateJan 22, 2027
Dividend Gr. 3/5Y0.00% 0.00%
Payout13.49%
Employees11000
IPOJul 06, 1965

Ratios

P/E70.92
Forward P/E26.85
PEG3.01
P/S6.07
P/B2.46
P/C30.09
P/FCF30.24
EV/EBITDA22.34
EV/Sales6.81
Quick Ratio2.10
Current Ratio2.65
Debt/Eq0.38
LT Debt/Eq0.38
Option/ShortYes / Yes

Earnings

EPS (ttm)2.26
EPS next Y5.96
EPS next Q1.61
EPS this Y7.20%
EPS next Y9.86%
EPS next 5Y8.92%
EPS past 3/5Y-22.75% -20.40%
Sales past 3/5Y-4.82% -5.47%
EPS Y/Y TTM-10.40%
Sales Y/Y TTM4.56%
EPS Q/Q37.01%
Sales Q/Q4.29%
EarningsNov 03 BMO
EPS/Sales Surpr.6.42% 2.14%

Ownership

Insider Own0.47%
Insider Trans-1.71%
Inst Own105.06%
Inst Trans4.64%
ROA2.14%
ROE3.45%
ROIC2.53%
Gross Margin49.15%
Oper. Margin16.44%
Profit Margin8.61%
SMA201.34%
SMA507.07%
SMA20040.87%
Trades-

Technical

Shs Outstand111.62M
Shs Float111.06M
Short Float5.88%
Short Ratio3.43
Short Interest6.53M
52W High171.74 -6.84%
52W Low81.22 97.00%
Volatility5.57% 4.44%
ATR (14)7.43
RSI (14)54.84
Beta1.08
Rel Volume0.05
Avg Volume1.90M
Volume4,397

Performance

Perf Week0.36%
Perf Month3.17%
Perf Quarter36.17%
Perf Half Y68.40%
Perf YTD65.37%
Perf Year69.65%
Perf 3Y89.37%
Perf 5Y-10.62%
Perf 10Y214.34%
Recom2.57
Target Price174.57
Prev Close159.10
Price160.00
Change %0.57%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 04, 2026UpgradeCCFRAHold → Buy
Oct 06, 2026InitiatedWWilliam BlairOutperform
Sep 09, 2026ResumedUUBSNeutral$140-12.5%
Sep 01, 2026InitiatedRRBC Capital MktsSector Perform$135-15.6%
Jun 26, 2026ResumedBBernsteinMkt Perform$115-28.1%
Jun 02, 2026ResumedWWolfe ResearchPeer Perform
Apr 14, 2026DowngradeBBarclaysOverweight → Equal Weight$95-40.6%
Dec 15, 2025DowngradeBBofA SecuritiesBuy → Neutral$110-31.2%
Dec 09, 2025InitiatedGGoldmanNeutral$105-34.4%
Oct 16, 2025InitiatedGGuggenheimNeutral

Peers

Mkt cap
TickerCompanyMkt cap
DHRDanaher Corp165.12B
AAgilent Technologies Inc50.18B
QGENQiagen NV10.39B
TMOThermo Fisher Scientific Inc265.76B
BIOBio-Rad Laboratories Inc10.41B
WATWaters Corp46.74B
MTDMettler-Toledo International Inc34.84B
TECHBio-Techne Corp11.41B
ILMNIllumina Inc32.96B
BRKRBruker Corp9.66B

Insider trading

latest 14 of 24
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Gonzales AnitaVP and CAOOct 01 '26Sale155.488413,0607,117Oct 02 04:05 PM
Gonzales AnitaOfficerOct 01 '26Proposed Sale155.488413,060Oct 01 10:48 AM
Krakowiak MaxwellPlease See RemarksSep 21 '26Sale144.531,631235,72814,781Sep 23 04:05 PM
Krakowiak MaxwellOfficerSep 21 '26Proposed Sale144.531,631235,728Sep 21 10:49 AM
Vohra Tajinder SPlease See RemarksSep 16 '26Sale140.887,3301,032,6506,635Sep 18 04:05 PM
Vohra Tajinder SOfficerSep 16 '26Proposed Sale140.887,3301,032,650Sep 16 09:55 AM
Gonzales AnitaVice President and CAOJul 20 '26Sale109.48859,3067,201Jul 22 04:05 PM
Gonzales AnitaOfficerJul 20 '26Proposed Sale109.48859,306Jul 20 09:40 AM
Gonzales AnitaVice President and CAOApr 20 '26Sale92.80807,4247,319Apr 22 04:05 PM
Gonzales AnitaOfficerApr 20 '26Proposed Sale92.80807,424Apr 20 09:55 AM
Victor MiriamePlease See RemarksFeb 24 '26Option Exercise95.741,862178,26819,984Feb 26 04:05 PM
Victor MiriamePlease See RemarksFeb 24 '26Sale97.131,862180,85618,122Feb 26 04:05 PM
McMurry-Heath MichelleDirectorFeb 23 '26Sale97.2660058,3564,233Feb 25 04:05 PM
Victor MiriameOfficerFeb 24 '26Proposed Sale97.131,862180,856Feb 24 11:21 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
VOOVanguard S&P 500 ETFAUM: 1057.81B
VBVanguard Morningstar Small-Cap ETFAUM: 79.96B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.22B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.82B
IVViShares Core S&P 500 ETFAUM: 875.00B
SPYSPDR S&P 500 ETF TrustAUM: 791.88B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.54B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.50B
TCAFT. Rowe Price Capital Appreciation Equity ETFAUM: 7.64B

News

latest 14 of 206
  • Revvity Inc. stock outperforms competitors on strong trading day (MarketWatch) +7.84%
  • Revvity Shares Jump Nearly 6% as Q3 Earnings Beat Forecasts and 2026 Guidance Improves (InvestorsHub)
  • Revvity Faced Off With 'Elevated Investor Expectations' - And Won (Investor's Business Daily)
  • Revvity Beats As Life Sciences Swings Back To Growth, But Q4 Guide Shows Some Of Q3 Was Borrowed (Earnings Whispers)
  • Revvity: Q3 Earnings Snapshot (Associated Press)
  • Loading…
  • Revvity Announces Financial Results for the Third Quarter of 2026 (Business Wire)
  • Revvity Board Declares Quarterly Dividend (Business Wire) -5.30%
  • After A 39% Rally, Revvity Must Turn Its Record Instrument Backlog Into Third-Quarter Shipments (Earnings Whispers)
  • Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows (Business Wire)
  • Revvity to Present at Upcoming Investor Conferences (Business Wire)
  • Revvity to Host Investor Day (Business Wire)
  • Revvity to Hold Earnings Call on November 3, 2026 (Business Wire)
  • Revvity Inc. stock outperforms competitors on strong trading day (MarketWatch) +6.03%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-031.3801.2970.560709.61694.7317
2026Q22026-08-041.4101.2140.464711702.9611
2026Q12026-05-051.0401.0160.364711.12704.0716
2025Q42026-02-021.7001.5700.871772.06764.9418
2025Q32025-10-271.1801.1410.407698.95699.3618
2025Q22025-07-281.1801.1480.468720.28710.7618
2025Q12025-04-281.0100.9490.34566566119
2024Q42025-01-311.4201.3680.780729.58727.9119
2024Q32024-11-041.2801.1260.764684.25679.6619
2024Q22024-07-291.2201.1220.641691.89690.3318
2024Q12024-04-290.9800.9430.224650.13647.2516
2023Q42024-02-011.2501.1650.832696.11677.1317
2023Q32023-10-301.1801.1940.077670.95695.415
2023Q22023-08-011.2101.1890.284709.27708.3816
2023Q12023-05-111.0100.9994.503675.07678.914
2022Q42023-02-141.7001.6391.088741.421,02911

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY4.1004.0742.0412,8842,881
2020FY8.3007.3606.4953,7843,654
2021FY11.36011.0388.0845,0704,976
2022FY7.9507.7844.5023,3134,589
2023FY4.6504.560-0.9492,7512,732
2024FY4.9004.8472.4092,7562,754
2025FY5.0604.9372.0702,8562,848
2026FY-5.425--2,866
2027FY-5.959--3,030
2028FY-6.538--3,193
2029FY-7.075--3,364
2030FY-7.793--3,580

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-031502759.13754.58764.4
2026Q4S2026-10-181500759.78751.86768
2026Q4S2026-10-131571759.78751.86768
2026Q4S2026-10-091571759.76751.86768
2026Q4S2026-10-021571759.78751.86768
2026Q4S2026-09-281471759.92751.86768
2026Q4S2026-09-251581759.28750.2768
2026Q4S2026-09-081681759.02750.2768
2026Q4S2026-09-011581759.02750.2768
2026Q4S2026-08-311581758.86750.2768
2026Q4S2026-08-121481758.69750.2768
2026Q4S2026-08-041491758.69750.2768
2026Q4S2026-07-211211749.73733.26771
2026Q4S2026-07-191212749.73733.26771

Estimate history

EPS, annual1.022.1412.0416.4958.0844.502-0.9492.4092.0762.256
Period201720182019202020212022202320242025TTM
EPS, quarterly0.7640.780.3450.4680.4070.8710.3640.4640.56
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2256.9822777.9962883.6733782.7453827.8083311.8222750.5712755.0262856.0512941.76
Period201720182019202020212022202320242025TTM
Sales, quarterly684.049729.372664.762720.284698.949772.056711.118729.688728.899
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual110.361110.597111.14112.09126.241126.3123.426120.646112.281111.584
Period201720182019202020212022202320242025MRQ
Shares, quarterly122.091120.646119.409116.331114.03112.281111.629111.584-
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,941.762,856.052,755.032,750.573,311.823,827.813,782.742,883.672,778.00
Cost of Goods Sold Incl. D&A1,530.491,486.191,432.371,428.381,551.091,545.851,792.231,590.621,526.76
Gross Profit1,411.271,369.871,322.661,322.191,760.732,281.951,990.511,293.061,251.24
Selling, General and Administrative Excl. Other957.03942.06912.14922.70979.61941.95970.72887.57880.27
Research and Development213.15215.84196.84216.58221.62200.34205.39189.34186.10
Other Operating Expense-0.000.000.000.000.000.000.000.00
Operating Income454.24427.81410.52399.49781.121,340.011,019.79405.48370.97
Interest Expense92.0392.1996.2898.81103.95102.1349.7163.6366.98
Unusual Expense97.9482.6355.82132.8554.1870.5633.5171.2558.78
Net Income Before Taxes282.77268.28316.13182.98651.841,203.58906.36237.14257.68
Income Taxes30.0028.3933.053.47139.16314.15178.279.3920.21
Consolidated Net Income253.74239.88283.07179.50512.68889.44728.10227.75237.47
Net Income From Continuing Operations253.74239.88283.07179.50512.68889.44728.10227.75237.47
Net Income253.74242.02295.83-118.38569.18943.16728.10227.56238.79
EPS (Recurring)2.882.572.73-0.204.808.516.702.492.51
EPS (Basic, Before Extraordinaries)-2.082.41-0.954.518.126.532.052.16
EPS (Diluted)2.262.082.41-0.954.508.086.492.042.14
EBITDA867.33833.15838.37831.261,208.121,651.451,266.30619.51551.56
Non-Operating Income (Expense)18.5115.2857.7015.1528.8536.27-30.20-33.4612.47
Other After Tax Adjustments-0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-17.5529.8130.8138.7213.8111.9319.9115.17
Price To Earnings Ratio70.4370.4345.3518.3729.3524.8722.1447.5936.71
Price To Sales Ratio5.763.954.994.965.356.134.253.753.10
Gross Margin47.9747.9648.0148.0753.1659.6252.6244.8445.04
Operating Margin15.4414.9814.9014.5223.5935.0126.9614.0613.35
Net Margin8.638.4710.74-4.3017.1924.6419.257.898.60
Shares Outstanding-112.28120.65123.43126.30126.24112.09111.14110.60
Market Capitalization17,753.3317,753.3313,583.1613,489.6217,712.0325,373.7716,068.2710,787.918,737.82

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue728.90729.69711.12772.06698.95720.28664.76729.37
Cost of Goods Sold Incl. D&A395.01362.92373.56399.00373.05376.51337.52369.68
Gross Profit333.89366.77337.56373.06325.90343.77327.25359.69
Selling, General and Administrative Excl. Other238.75240.87249.95227.47235.04238.97239.28227.40
Research and Development48.1148.9757.8958.1850.8053.2753.6049.21
Other Operating Expense-0.000.000.000.000.000.000.00
Operating Income95.14125.9087.61145.5990.86104.7987.97132.29
Interest Expense20.8122.9924.7223.5122.7722.9422.9622.78
Unusual Expense-1.6341.8315.9341.8113.5715.9912.6719.55
Net Income Before Taxes77.6863.5349.9991.5655.6968.6552.3894.56
Income Taxes15.0610.059.10-4.218.4613.4310.716.17
Consolidated Net Income62.6253.4840.8995.7747.2255.2241.6788.38
Net Income From Continuing Operations62.6253.4840.8995.7747.2255.2241.6788.38
Net Income62.6251.8240.7298.5846.9555.0541.4495.04
EPS (Recurring)0.550.730.461.130.490.560.420.89
EPS (Basic, Before Extraordinaries)-0.460.360.880.410.470.340.78
EPS (Diluted)0.560.460.360.870.410.470.340.78
EBITDA198.06227.94192.66248.67192.92207.57185.39237.32
Non-Operating Income (Expense)1.732.463.0311.301.162.780.044.61
Other After Tax Adjustments-0.000.000.000.000.000.000.00
Stock Option Compensation Expense-2.202.2812.74-1.791.6523.81
Price To Earnings Ratio70.4352.7441.9148.3837.1938.2443.9245.35
Price To Sales Ratio5.764.363.433.843.454.114.584.95
Gross Margin45.8150.2647.4748.3246.6347.7349.2349.32
Operating Margin13.0517.2512.3218.8613.0014.5513.2318.14
Net Margin8.597.105.7312.776.727.646.2313.03
Shares Outstanding-111.58111.63112.28114.03116.33119.41120.65
Market Capitalization17,753.3312,412.179,795.0610,969.1310,173.8011,400.3912,711.5513,583.16

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments919.871,164.451,604.29455.40604.34402.61191.89163.11202.13
Short Term Receivables744.67632.40632.81612.78707.941,155.11725.18632.67552.30
Inventories379.50367.59428.06405.46425.89514.57356.94338.35351.68
Other Current Assets195.71185.17335.931,814.92702.61166.63100.36100.5193.84
Total Current Assets2,239.752,349.613,001.093,288.562,440.782,238.921,374.381,234.631,199.95
Net Property, Plant & Equipment644.69649.93664.74671.30649.57575.54485.50318.59298.07
Total Investments and Advances93.1396.7885.10110.5880.982.152.912.452.21
Long-Term Note Receivable38.0128.1629.5934.0429.9622.5119.68--
Intangible Assets8,960.509,104.549,555.879,858.9410,448.974,812.814,394.514,152.274,349.14
Deferred Tax Assets32.655.618.1618.5318.5365.5260.0079.3167.28
Other Assets159.69157.84220.12147.911,331.76242.87201.59188.26174.82
Total Assets12,168.4112,392.4813,564.6714,129.8515,000.557,960.316,538.565,975.526,091.46
Short Term Debt Incl. Current Port. of LT Debt618.8623.82754.78502.1533.55421.2846.5514.86217.31
Accounts Payable185.46167.46204.12272.83324.81327.32235.85220.95222.09
Income Tax Payable80.5674.4088.1645.6288.2897.4129.8830.6910.80
Other Current Liabilities446.35387.41403.40723.89767.10806.18450.55505.14500.70
Total Current Liabilities1,331.25653.101,450.461,544.481,213.741,652.19762.83771.63950.90
Long Term Debt2,779.343,301.983,310.524,093.325,127.131,798.102,210.441,876.621,788.80
Provision for Risks Charges0.000.000.000.000.000.000.801.402.30
Deferred Tax Liabilities487.25456.10----224.94227.33316.93
Other Liabilities320.21314.42930.951,109.181,518.43774.53525.73513.58529.34
Total Liabilities4,918.054,725.605,691.936,746.987,859.314,224.823,724.743,390.573,588.28
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7,250.367,666.877,872.747,382.887,141.243,735.492,813.822,584.952,503.19
Total Shareholders Equity7,250.367,666.877,872.747,382.887,141.243,735.492,813.822,584.952,503.19
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity7,250.367,666.877,872.747,382.887,141.243,735.492,813.822,584.952,503.19
Total Liabilities & Stockholders Equity12,168.4112,392.4813,564.6714,129.8515,000.557,960.316,538.565,975.526,091.46
Book Value Per Share64.5763.5563.7958.4656.5733.3325.3223.3722.68
Tangible Book Value Per Share-15.23-11.92-13.64-19.60-26.20-9.61-14.22-14.17-16.73
Full-Time Employees11,00011,00011,50016,70016,70014,00013,00012,50011,000
Price to Book Ratio2.461.721.752.503.554.313.843.363.18
Return on Assets1.952.181.303.527.7510.043.643.943.03
Return on Equity3.223.642.357.0616.3522.238.449.336.74
Return on Invested Capital2.412.70-1.064.967.6913.164.535.352.63
Quick Ratio1.403.031.771.871.661.041.331.160.89
Current Ratio1.683.602.072.132.011.361.801.601.26

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income253.20241.20270.38693.09569.18943.16727.89227.56237.93
Depreciation413.09405.34427.85431.77427.00311.44246.51214.03180.59
Other Funds (Non Cash)141.9792.1850.60-518.5852.5278.4966.03147.9074.35
Funds from Operations746.78677.24646.60482.62942.781,277.761,011.30528.13441.77
Extraordinary Item-0.000.000.000.000.000.000.000.00
Changes in Working Capital-93.10-96.78-18.30-391.35-262.97132.99-119.12-164.66-130.73
Cash from Operating Activities653.68580.46628.3091.27679.811,410.75892.18363.47311.04
Capital Expenditures-65.36-73.52-86.65-1,302.98-85.63-86.02-77.51-81.33-93.25
Net Assets From Acquisitions-67.060.000.00-2.09-7.52-3,982.22-411.50-400.40-97.69
Sale of Fixed Assets and Businesses12.270.300.000.1514.511.464.280.5538.03
Purchase or Sale of Investments2.30-0.39705.91-6.30-47.18-23.13-20.06-6.39-7.02
Purchase of Investments-5.20-0.39-6.59-6.30-47.18-23.13-20.06-6.39-7.02
Sale Or Maturity of Investments7.500.00712.500.000.000.00-0.000.00
Other Uses-0.000.000.00-15.91-22.960.000.000.00
Other Sources0.0056.25156.902,624.738.890.110.280.000.07
Cash from Investing Activities-117.83-17.35776.161,313.52-132.85-4,112.76-504.50-487.57-159.86
Cash Dividends Paid-31.42-32.80-34.45-34.97-35.34-32.37-31.21-31.06-31.01
Change in Capital Stock-260.65-817.89-361.88-384.54-66.52-47.9530.7313.42-32.61
Repurchase of Common Pref Stock-270.87-820.82-369.58-388.88-80.64-73.07-6.94-6.31-57.45
Sale of Common Pref Stock10.212.927.704.3414.1125.1237.6719.7324.83
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-571.56-0.52-723.07-517.50-559.173,042.99-187.47198.99-68.68
Change in Long Term Debt-571.56-0.52-723.07-517.50-559.173,042.99-187.47198.99-68.68
Issuance of Long Term Debt25.000.000.006.31240.004,955.39714.702,436.731,223.71
Reduction of Long Term Debt-596.56-0.52-723.07-523.81-799.17-1,912.41-902.17-2,237.74-1,292.38
Net Financing Active Other Cash Flow-0.35-3.84-8.83-10.12-0.77-21.00-14.92-31.22-46.93
Other Financing Activities Uses-0.35-3.84-8.83-10.12-0.77-21.00-14.92-31.22-46.93
Cash from Financing Activities-863.98-855.05-1,128.23-947.12-661.802,941.66-202.87150.13-179.23
Exchange Rate Effect-12.6448.52-26.15-14.05-33.75-22.9325.91-0.45-8.00
Net Change in Cash-338.61-243.42250.08443.63-148.59216.72210.7225.58-36.05
Free Cash Flow588.31506.94541.659.90594.181,324.73814.67287.14217.78
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow30.4323.7927.12-31.7218.1520.5342.2646.15
Deferred Taxes & Investment Tax Credit--61.48-102.23-123.66-105.92-55.33-29.12-61.35-51.10

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments593.401,023.66860.75919.87932.58992.99
Short Term Receivables687.33709.17691.38744.67680.26661.14
Inventories388.85378.50387.50379.50379.92388.47
Other Current Assets191.81186.39188.68195.71151.04193.59
Total Current Assets1,861.392,297.722,128.322,239.752,143.792,236.18
Net Property, Plant & Equipment597.69607.20628.89644.69668.17676.19
Total Investments and Advances0.570.530.0093.130.000.00
Intangible Assets8,725.708,831.808,917.288,960.509,026.569,129.36
Deferred Tax Assets---32.65--
Other Assets304.99276.39322.10159.69300.44321.06
Total Assets11,490.3512,045.8311,996.5912,168.4112,138.9512,362.79
Short Term Debt Incl. Current Port. of LT Debt0.00572.16575.83618.86583.840.23
Accounts Payable163.27165.74169.68185.46175.80178.15
Income Tax Payable---80.56--
Other Current Liabilities538.21538.46493.13446.35463.10493.43
Total Current Liabilities701.481,276.361,238.641,331.251,222.74671.81
Long Term Debt2,765.032,769.362,774.352,779.342,785.163,374.63
Provision for Risks Charges-0.000.000.000.000.00
Deferred Tax Liabilities---487.25--
Other Liabilities752.73771.36800.86320.21755.15760.18
Total Liabilities4,219.244,817.084,813.854,918.054,763.064,806.62
Non-Equity Reserves-0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7,271.117,228.767,182.747,250.367,375.907,556.17
Total Shareholders Equity7,271.117,228.767,182.747,250.367,375.907,556.17
Accumulated Minority Interest-0.000.000.000.000.00
Total Equity7,271.117,228.767,182.747,250.367,375.907,556.17
Total Liabilities & Stockholders Equity11,490.3512,045.8311,996.5912,168.4112,138.9512,362.79
Book Value Per Share-64.7864.3464.5764.6864.95
Tangible Book Value Per Share--14.37-15.54-15.23-14.48-13.52
Full-Time Employees---11,000--
Price to Book Ratio2.461.731.361.501.351.51
Return on Assets2.151.941.961.951.872.16
Return on Equity3.463.213.233.223.043.61
Return on Invested Capital0.620.520.410.980.460.50
Quick Ratio2.101.501.411.401.442.75
Current Ratio2.651.801.721.681.753.33

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income62.3051.8240.7298.3645.2456.50
Depreciation102.92102.04105.06103.08102.06102.78
Other Funds (Non Cash)35.7156.169.1840.9126.9123.83
Funds from Operations200.93210.02154.95180.87174.21183.10
Extraordinary Item-0.000.000.000.000.00
Changes in Working Capital-36.38-18.08-39.721.09-35.71-48.86
Cash from Operating Activities164.55191.94115.23181.96138.50134.25
Capital Expenditures-14.35-11.07-19.77-20.17-18.50-18.87
Net Assets From Acquisitions0.000.22-67.280.000.000.00
Sale of Fixed Assets and Businesses0.003.049.160.070.000.00
Purchase or Sale of Investments-1.253.260.68-0.390.000.00
Purchase of Investments-1.25-3.560.00-0.390.000.00
Sale Or Maturity of Investments0.006.820.680.000.000.00
Other Uses-1.05-1.050.03-0.030.00
Other Sources0.000.000.000.0037.509.38
Cash from Investing Activities-15.60-3.50-78.27-20.4518.97-9.49
Cash Dividends Paid-7.81-7.81-7.84-7.96-8.13-8.28
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Change in Capital Stock3.39-15.00-81.06-167.99-205.03-293.91
Repurchase of Common Pref Stock-0.10-15.99-86.50-168.28-205.03-293.91
Sale of Common Pref Stock3.481.005.440.290.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-571.190.000.00-0.36-0.06-0.05
Change in Long Term Debt-571.190.000.00-0.36-0.06-0.05
Issuance of Long Term Debt25.000.000.000.000.000.00
Reduction of Long Term Debt-596.190.000.00-0.36-0.06-0.05
Net Financing Active Other Cash Flow0.00-0.350.000.00-1.86-0.16
Other Financing Activities Uses0.00-0.350.000.00-1.86-0.16
Cash from Financing Activities-575.61-23.16-88.89-176.31-215.07-302.40
Exchange Rate Effect-5.71-2.56-7.633.26-2.8131.95
Net Change in Cash-430.21162.72-59.56-11.54-60.41-145.70
Free Cash Flow150.20180.8795.45161.79120.00115.38
Price to Free Cash Flow30.4324.1321.6123.1021.0324.64

Revenue breakdown

Product2024: 2.34B 2025: 2.39B
Service2024: 416.82M 2025: 466.07M
China2024: 450.01M 2025: 425.06M
Germany2024: 162.58M 2025: 177.66M
Other International2024: 931.71M 2025: 1.00B
United Kingdom2024: 112.88M 2025: 126.85M
United States2024: 1.10B 2025: 1.13B
Diagnostics2024: 1.36B 2025: 1.42B
Life Sciences2024: 1.40B 2025: 1.43B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.88%6.5M111.1M1.85M
2026-10-155.76%6.4M111.1M1.82M
2026-09-305.67%6.3M111.1M1.72M
2026-09-155.60%6.2M111.1M1.58M
2026-08-315.68%6.3M111.1M1.47M
2026-08-145.78%6.4M111.1M1.49M
2026-07-316.35%7.1M111.0M1.52M
2026-07-156.70%7.4M111.0M1.47M
2026-06-306.88%7.6M111.0M1.42M
2026-06-157.49%8.3M111.0M1.28M
2026-05-297.88%8.7M111.0M1.27M
2026-05-158.58%9.5M111.0M1.19M
2026-04-307.90%8.8M111.3M1.19M
2026-04-157.53%8.4M111.3M1.23M
2026-03-317.41%8.2M111.3M1.34M
2026-03-137.73%8.6M111.3M1.36M
2026-02-277.36%8.2M111.3M1.33M
2026-02-137.15%8.0M111.3M1.52M
2026-01-306.26%7.1M112.9M1.44M
2026-01-156.14%6.9M112.9M1.43M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call85.0072.6076.2081.802.7711.000.000.959-0.2960.023
call90.0067.9071.500.002.6540.000.000.956-0.2920.024
call95.0062.9066.300.002.3950.000.000.952-0.2870.026
call10057.7061.400.002.2210.000.000.948-0.2820.028
call10553.0056.500.002.0590.000.000.943-0.2770.030
call11048.1051.5047.401.8771.000.000.938-0.2700.032
call11542.9046.700.001.7520.000.000.932-0.2640.034
call12038.2041.700.001.5730.000.000.925-0.2560.037
call12533.3036.900.001.4470.000.000.916-0.2470.040
call13029.0032.1022.851.3131.000.000.905-0.2370.044
call13524.0027.4031.291.1911.000.000.892-0.2250.049
call14019.9022.700.001.0610.000.000.827-0.3190.067
call14515.0018.5016.150.9836.000.000.755-0.4000.082
call15011.1014.0012.590.8501640.000.693-0.4010.092
call1558.0010.608.900.8061661660.607-0.4270.100
call1604.408.306.600.83010398.000.511-0.4200.104
call1652.555.104.000.7198705.000.408-0.3870.101
call1702.102.702.980.6272,0413500.284-0.2920.089
call1751.003.501.750.7606221.000.244-0.3200.082
call1800.001.901.000.7712201.000.183-0.2750.069
call1850.002.650.880.87711.000.000.166-0.2930.065
call1900.002.501.030.9759.000.000.154-0.3090.062
call1950.002.351.971.0682080.000.143-0.3230.059
call2000.002.300.751.1572.000.000.135-0.3350.057
call2100.002.200.001.3220.000.000.122-0.3570.053
put85.000.002.150.002.4790.000.00-0.040-0.2850.023
put90.000.002.200.002.2920.000.00-0.044-0.2820.024
put95.000.002.200.002.1080.000.00-0.048-0.2770.026
put1000.002.200.001.9330.000.00-0.052-0.2720.028
put1050.002.250.701.7653.000.00-0.057-0.2660.030
put1100.002.301.051.6032.000.00-0.062-0.2590.032
put1150.002.250.051.3682.000.00-0.061-0.2110.033
put1200.002.801.501.2972.000.00-0.075-0.2430.037
put1250.002.900.361.1501050.00-0.084-0.2340.040
put1300.151.701.151.006492112-0.095-0.2240.044
put1350.001.250.900.8641,1330.00-0.108-0.2110.049
put1401.052.351.330.9045411.00-0.173-0.3040.067
put1450.703.803.810.9301,1060.00-0.245-0.3850.082
put1501.754.602.520.8358340.00-0.307-0.3850.092
put1553.806.504.400.825167185-0.393-0.4110.100
put1606.107.907.900.72135.001.00-0.489-0.4030.104
put1658.2011.4010.300.77779.0080.00-0.591-0.3690.101
put17011.5014.0011.100.69212.000.00-0.716-0.2740.089
put17515.5018.0013.300.7084.000.00-0.756-0.3020.082
put18019.8023.200.000.8530.000.00-0.817-0.2560.069
put18524.3027.700.000.8910.000.00-0.834-0.2740.065
put19029.1032.800.001.0110.000.00-0.846-0.2890.062
put19534.0037.600.001.0700.000.00-0.857-0.3030.059
put20038.8042.500.001.1410.000.00-0.865-0.3140.057
put21049.3052.500.001.3070.000.00-0.878-0.3350.053

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-10-04SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-07SCHEDULE 13G/ASEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-234Statement of changes in beneficial ownership of securities2026-09-21SEC
2026-09-21144Filing for proposed sale of securities under Rule 144.SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-16144Filing for proposed sale of securities under Rule 144.SEC
2026-09-08SCHEDULE 13G/ASEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-07-05SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-224Statement of changes in beneficial ownership of securities2026-07-20SEC
2026-07-20144Filing for proposed sale of securities under Rule 144.SEC
2026-07-2025-NSESEC
2026-06-2311-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-01SDSpecialized Disclosure ReportSEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-04-05SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100013.06K1
2026-09001.27M2
2026-080000
2026-07009.31K1
2026-060000
2026-050000
2026-04007.42K1
2026-030000
2026-02004.67M5
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
-

Funds

Fund% owned
VANGUARD SHORT-TERM INVESTMENT-GRADE FUND12.25%
Baird Aggregate Bond Fund10.76%
Inspire Corporate Bond ETF10.75%
Baird Core Plus Bond Fund10.55%
VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND10.54%
T. Rowe Price Capital Appreciation Fund10.20%
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND9.86%
Brown Advisory Sustainable Bond Fund8.47%
VANGUARD INTERMEDIATE-TERM BOND INDEX FUND7.17%
T. Rowe Price New Income Fund, Inc.6.79%

OakChart. RVTY. Cached 15 minutes.